as of 09-03-2026 3:54pm EST
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 254.1M | IPO Year: | 2016 |
| Target Price: | $110.00 | AVG Volume (30 days): | 57.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $23.15 - $97.97 | Next Earning Date: | 05-22-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -72.22% | Revenue Growth (next year): | 223.84% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
10% Owner
Avg Cost/Share
$68.95
Shares
900
Total Value
$62,054.01
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$69.52
Shares
783
Total Value
$54,434.16
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$68.67
Shares
5,217
Total Value
$356,169.70
Owned After
526,900
10% Owner
Avg Cost/Share
$69.54
Shares
35,113
Total Value
$2,434,156.49
Owned After
526,900
10% Owner
Avg Cost/Share
$71.50
Shares
951
Total Value
$67,996.50
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$73.43
Shares
920
Total Value
$67,555.97
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$73.89
Shares
775
Total Value
$57,262.66
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$73.95
Shares
229
Total Value
$16,934.55
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$73.69
Shares
300
Total Value
$22,107.00
Owned After
526,900
SEC Form 4
10% Owner
Avg Cost/Share
$71.97
Shares
1,400
Total Value
$100,758.98
Owned After
526,900
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | SLGL | 10% Owner | Sep 2, 2026 | Buy | $68.95 | 900 | $62,054.01 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Sep 1, 2026 | Buy | $69.52 | 783 | $54,434.16 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Aug 31, 2026 | Buy | $68.67 | 5,217 | $356,169.70 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Aug 28, 2026 | Buy | $69.54 | 35,113 | $2,434,156.49 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Aug 12, 2026 | Buy | $71.50 | 951 | $67,996.50 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jul 14, 2026 | Buy | $73.43 | 920 | $67,555.97 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jul 13, 2026 | Buy | $73.89 | 775 | $57,262.66 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jul 10, 2026 | Buy | $73.95 | 229 | $16,934.55 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jul 8, 2026 | Buy | $73.69 | 300 | $22,107.00 | 526,900 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jul 2, 2026 | Buy | $71.97 | 1,400 | $100,758.98 | 526,900 |
See how SLGL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.